Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Researchers and Healthcare Providers
 Research Grants Program
-Medical and Scientific Advisory Council
 Recent Recommendations
 What is MASAC?
 All MASAC Recommendations
 MASAC Members
 Nursing Working Group
 Social Work Working Group
 Physical Therapy Working Group
 Comprehensive Medical Care - Hemophilia Treatment Centers
 Cell Based Coagulation Animation
 Rare Bleeding and Clotting Disorders Resource Room
 The Partners in Bleeding Disorders Education Program
 NHF/Novo Nordisk HANDI Library

 

 

 
MASAC Recommendation #109- MASAC Resolution Concerning Participation in AIDS Cli
 
MASAC Recommendation #109

MASAC Resolution Concerning Participation in AIDS Clinical Trials by HIV-Infected Persons with Bleeding Disorders


The following resolution was approved by the Medical and Scientific Advisory Council (MASAC) on February 23, 2001, and adopted by the NHF Board of Directors on March 4, 2001.

MASAC supports participation in AIDS clinical trials by HIV-infected persons with hemophilia and other bleeding disorders. MASAC specifically supports the optimization of inclusion criteria to allow such individuals to participate in AIDS clinical trials. MASAC also supports development of studies to evaluate treatment of other complications that affect the bleeding disorders population such as HCV co-infection. Reference: Research Priorities in Hemophilia: HCV and HIV Disease, A Blueprint for Action. White Paper, National Hemophilia Foundation, New York, April 1999.